Metastatic bladder cancer immunotherapy outcomes better with antihistamines, study shows
Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...
Massive data analysis advances understanding of how immunotherapy works
What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...
Science Daily1d
Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
GlobalData on MSN13h
FDA authorises ImmunityBio’s BCG alternative to treat bladder cancer
ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
PharmiWeb3d
The Rise of Immunotherapies in the Bladder Cancer Market
The bladder cancer market is poised for transformative growth between 2025 and 2035, driven by rising global incidence rates, ...
News Medical on MSN1d
Radiation and immunotherapy help preserve bladders in patients with muscle-invasive bladder cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
Cure Today11h
Bavencio and BSC Extends Survival in Bladder Cancer, Regardless of Diabetes Status
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
GlobalData on MSN3d
AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trial
The treatment regimen reduced the risk of developing distant metastases or death due to bladder cancer by 33%.
Renal & Urology News1d
Real-World Muscle-Invasive Bladder Cancer Treatment Patterns Revealed
Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the ...
PMLiVE1d
AstraZeneca shares promising phase 3 results for Imfinzi in bladder cancer
The phase 3 NIAGARA trial randomised 1,063 MIBC patients to receive Imfinzi plus neoadjuvant chemotherapy prior to bladder ...
PharmiWeb1d
Cancer Immunotherapy Market Size Worth $245.37 Bn…
The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...
Radiation plus combination immunotherapy may help preserve bladder in some patients with cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors ...